Objectives: This study aimed to clarify the relationship between body mass index (BMI) and patient characteristics, lifestyle factors, and cardiovascular disease (CVD)-related clinical data in women with rheumatoid arthritis (RA).
with RA, or the relationship between BMI and disease activity, ADL, and CVD-related clinical data in patients with RA. We aimed to clarify the relationships between BMI and lifestyle factors, and also compared ADL, disease activity, and CVD-related clinical data in female patients with RA divided into underweight, normal, and overweight categories based on BMI.
MATERIALS AND METHODS

Study Design
In this study, we used year 2011 data from 171 female RA outpatients and 170 age-matched controls without RA who participated in the TOMORROW study (UMIN: 000003876). TOMORROW is a 10-year prospective cohort study conducted in Osaka City University Medical School starting in 2010 that includes 208 Japanese patients with RA and 205 age-and sexmatched Japanese subjects without RA [12] . All of the study's subjects are older than 20 years and control subjects were recruited by mass media. We performed a sub-analysis of 2011 data in this cross-sectional study. This study was conducted with approval from the Ethics Committee at Osaka City University Medical School, and all participants provided written, informed consent based on the Declaration of Helsinki. A diagnosis of RA was made according to the American College of Rheumatology criteria [13] . Using the year 2010 baseline registration data gained through a questionnaire, we assessed subjects' basic status regarding smoking, alcohol intake, current exercise habits, current exercise restrictions from doctors, walking time per day, and history and treatment for diabetes mellitus, dyslipidemia, and hypertension. BMI was calculated as weight divided by square of height (kg/m 2 ), and we divided patients into three BMI categories: underweight (BMI < 18.5 kg/m 2 ; RA, n = 21; controls, n = 23), normal weight (BMI 18.5 and < 25 kg/m 2 ; RA, n=112; controls, n = 119), and overweight (BMI 25 kg/m 2 ; RA, n = 38; controls, n = 28) [14] . Because the number of subjects with a BMI > 30 kg/m 2 was limited in both the RA group (n = 7) and control group (n = 3), we included these subjects in the overweight category. We set the ideal body weight (IBW) as the square of height (m) 22 [15] .
Disease Activity and ADL Assessment
Disease Activity Score for 28 joints based on erythrocyte sedimentation rate (DAS28-ESR) was used to assess disease activity [16] , and the modified Health Assessment Questionnaire (mHAQ) was used to evaluate ADL [17] . Higher mHAQ scores indicate a lower ADL level.
Energy and Nutrient Intake Assessment
A brief-type dietary history questionnaire was used to assess energy and nutrient intake [18] , and we excluded one subject in both the RA and control groups who had low energy intake (less than 600 kcal per day) [12] .
Blood Chemistry and Physiological Assessment
We assessed systolic blood pressure (SBP), diastolic blood pressure (DBP), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), uric acid (UA), total cholesterol (T-chol), triglycerides (TG), high-density lipoprotein cholesterol, (HDL-chol), low-density lipoprotein cholesterol (LDL-chol), fasting plasma glucose (FPG), immunoreactive insulin (IRI), HbA1c, leptin, and adiponectin. Blood samples were collected after an overnight fast, and serum samples were stored at 80°C before analysis in 2010.
Statistical Analysis
Dr. SPSS II for Windows, version 11.0.1J (SPSS Japan Inc., Tokyo, Japan) was used for statistical analysis. Data are shown as number of subjects (%) or median (interquartile range [IQR] ) because data were not normal distribution. The Kruskal-Wallis test and chisquare test were used to analyze differences between the three groups, and the Jonckheere-Terpstra test was used to estimate the trend of the p value. Correlation coefficient (R) was calculated as an age adjusted value for adjusting variable collinearity; values > 0.20 represented a correlation. A p value < 0.05 was considered statistically significant.
RESULTS
Subjects' Characteristics Based on BMI Group
Subjects' characteristics by BMI group are shown in Table 1 . In the RA group, there were significant differences in age (p = 0.010), waist circumference (p < 0.001), mHAQ score (p = 0.035), and the number of patients with a history of smoking (p = 0.008) among the three groups. DAS28-ESR, the number of patients with a history of diabetes mellitus, and the number of patients with a history of hypertension had a tendency to differ among the three groups. Age had a tendency to increase with BMI. There were no significant differences in exercise or medication status among the three groups of patients with RA. In the control group, there was a significant difference between BMI groups in terms of exercise restriction, but there were no significant differences in exercise habits and walking time per day; other characteristics showed a similar trend to patients with RA. In the RA group, DAS28-ESR and mHAQ scores in the normal weight group were lower than scores in the underweight and overweight groups. We applied a quadratic curve to the scattergrams between BMI and both DAS28-ESR and mHAQ scores; these two parameters showed the lowest scores near a BMI of 22 kg/m 2 ( Figure 1) . We also assessed the relationship between BMI and both DAS28-ESR and mHAQ scores after adjusting for age. BMI didn't show the significant correlation between DAS28-ESR (r = 0.024) or mHAQ scores (r = 0.039) in whole RA group. In patients who had BMI < 22 kg/m 2 (n = 88), BMI showed no correlation with DAS28-ESR score (r = -0.06). However, there was a negative correlation between BMI and mHAQ score (r = -0.20) in these patients, and the mHAQ score showed a positive correlation with DAS28-ESR score (r = 0.40). In patients who had BMI >22 kg/m 2 (n = 83), BMI showed no correlation between DAS28-ESR (r = 0.15) or mHAQ scores (r = -0.12). However, in the overweight group, BMI showed a positive correlation with DAS28-ESR score (r = 0.27), but not with mHAQ score (r = 0.01). There was a positive correlation between DAS28-ESR and mHAQ scores in the overweight group (r = 0.24) (data not shown).
Energy and Nutrient Intake Based on BMI Category
Energy and nutrient intake status as crude values and intake per ideal body weight (IBW) are shown in Table 2 . In the RA group, energy (p = 0.041), protein (p = 0.003), and carbohydrate intake (p = 0.015) showed ); mHAQ, modified Health Assessment Questionnaire; DAS28-ESR, Disease Activity Score 28 based on erythrocyte sedimentation ratio; DM, diabetes mellitus; DL, dyslipidemia; HT, hypertension; DMARD, disease-modifying anti-rheumatic drug.
significant differences among the three BMI groups. Energy and nutrient intake per IBW also showed a significant difference among the three BMI groups and showed a positive trend with BMI. The overweight group showed a higher value for energy and nutrient intake compared with the normal and underweight groups. In the control group, carbohydrate intake per IBW in the overweight group was higher than in the normal weight and underweight groups. Table 3 shows blood chemistry and physiological data by BMI category. In the RA group, SBP (p = 0.001), DBP (p = 0.011), CRP (p = 0.014), UA (p = 0.004), TG (p = 0.005), FPG (p < 0.001), IRI (p < 0.001), HbA1c (p = 0.036), leptin (p < 0.001), and adiponectin (p = 0.007) showed significant differences among groups, and these parameters, excluding adiponectin, had a tendency to increase with BMI (p < 0.05 for trend). The control group showed similar trends.
Blood Chemistry and Physiological Data Based on BMI Category
DISCUSSION
In this study, we assessed and compared subject characteristics, disease activity, ADL, energy and nutrient intake, and some CVD risk-related clinical data based on BMI category in female patients with and without RA. In patients with RA, patient age showed a positive correlation with BMI. One report in Japan showed that obesity in older females was higher than that in younger females [19] , and our results in RA patients are consistent with this report. ADL and disease activity scores in the normal weight group were better than scores in the underweight and overweight groups, and these parameters were best at a BMI of 22 kg/m 2 . The reason the underweight group showed higher disease activity might be related to a report that suggested that high disease activity is caused by acute inflammation related to decreased skeletal muscle mass [9] . The reason for lower ADL in the underweight group may also be related to high disease activity that has been shown in underweight patients with RA [10] . Our results are consistent with these reports. Disease activity scores were higher and ADL was lower in the overweight group than in the normal weight group. In patients with RA, obesity is related to attenuation of medication effects, although the reason for this is unclear [8] . Obesity is also related to high disease activity in patients with RA [7] , and high disease activity is related to low ADL in patients with RA [20] . Based on these reports and our results, it is possible that patients with RA who are underweight or overweight may have higher disease activity or lower ADL than normal weight patients, and maintaining a normal weight might be a healthy status indicator in patients with RA. However, the benefit of weight control on disease activity and ADL in underweight or overweight patients with RA should be assessed.
In terms of energy and nutrient intake in patients with RA, energy, protein, and carbohydrate intake in the overweight group were higher than values in the normal weight and underweight groups. However, the status of energy and protein intake per IBW was similar in the underweight and normal weight groups. Carbohydrate intake per IBW showed a strong positive correlation with BMI in patients with RA, and the overweight control group also showed a higher carbohydrate intake per IBW than the underweight and normal weight control groups. In terms of weight loss in obese subjects, it is reported that the kind of energy source nutrient affects weight loss, and restriction from carbohydrate-derived energy is most effective for weight loss [21] . The current study also suggests that the kind of energy-derived nutrient affects weight in daily life, as our results showed a positive correlation between BMI and carbohydrate intake in patients with RA. Carbohydrate intake restriction in overweight patients with RA may contribute to weight loss, and an increase in carbohydrate intake in underweight patients with RA may help with weight gain to help patients maintain a normal weight.
In patients with RA, higher BMI was related to higher blood pressure, CRP, TG, FPG, IRI, leptin, and lower adiponectin. This trend was similar in our control population, and has been reported in a general population [2] . Our results suggest that weight control in overweight patients with RA may improve CVDrelated clinical data. It is reported that underweight in patients with RA is related to CVD risk [11] , although our data showed that underweight patients with RA had the most healthy CVD-related clinical data among the three BMI categories. CVD risk in patients with RA is not fully explained with only traditional CVD risk factors, such as hypertension, glucose intolerance, and dyslipidemia; inflammation and disease activity also affect CVD risk [6] . These facts and our results may suggest that normal weight patients with RA whose inflammation status, disease activity, and CVD-related clinical data were relatively good compared with underweight and overweight groups may represent a lower CVD risk group among RA patients.
This study has some limitations. First, this subanalysis is cross-sectional. Longitudinal and intervention studies are needed to clarify the etiology between BMI and disease activity, ADL, and CVDrelated clinical data. Second, we analyzed only women because the study population was limited. Data are also needed for male patients with RA. Third, in this study, although there was no significant difference in medication status for RA among three BMI category groups, some reports showed medications for RA treatment affected lipid metabolism profiles [22] [23] [24] . Fourth, we assessed Japanese population's data. Because of Asian ethnic characteristics, Japanese population with lower BMI might be susceptible to the change of obesity-related metabolism compared to other ethnics. The differences in baseline characteristic of BMI might affect the results in different studies [25, 26] . In this aspect, careful interpretation of the results regarding the effects of BMI in different ethnic population should be required.
CONCLUSIONS
In patients with RA, maintaining a normal weight may help keep disease activity, ADL, and CVD-related clinical data at relatively good levels. Energy intake, especially carbohydrates, may contribute to increased BMI in patients with RA.
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